Emulate
Emulate secures millions in latest financing round to expand product portfolio
Privately held company, Emulate, has secured a $36 million Series C financing round, the funds from which will be used to expand the company’s product suite and commercialisation of its Human Emulation System. Read more
Collaborative partnership forms to accelerate development of organs-on-chips tech
Privately-held company, Emulate, and the Innovative Medicines and Early Development Biotech Unit of pharmaceutical company AstraZeneca have formed a collaborative partnership to develop and embed organ-on-chips technology into laboratory research Read more
Strategic partnership will apply organ-chips to drug efficacy and safety
A strategic partnership has been formed between scientists from Emulate and Roche (F Hoffman La-Roche) for the application of organ-chips in the testing of the efficacy and safety of new antibody therapeutics and combination therapies. Read more
Janssen uses Emulate's organs-on-chips to improve candidate design and selection
Johnson & Johnson's Janssen Biotech is to deploy Emulate’s organs-on-chips platform to better predict the potential human response of drug candidates and improve the drug development process under a recently formed research collaboration. Read more
